Business / Deals
Abbott to Acquire Exact Sciences for $23 Billion
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Exact Sciences (NASDAQ: EXAS) for approximately $23 billion. This acquisition will enable Abbott to lead in the fast-growing cancer diagnostics segments, enhancing early det...